Cargando…
Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review
Second-generation antipsychotics are common candidates for the adjunctive treatment of major depressive disorder and for the treatment of schizophrenia. However, unmet needs remain in the treatment of both disorders. Considering schizophrenia, antipsychotics are the most common treatment and have de...
Autores principales: | Mallet, Jasmina, Gorwood, Philip, Le Strat, Yann, Dubertret, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822140/ https://www.ncbi.nlm.nih.gov/pubmed/31406978 http://dx.doi.org/10.1093/ijnp/pyz043 |
Ejemplares similares
-
Polygenic Risk Scores Shed Light on the Relationship between Schizophrenia and Cognitive Functioning: Review and Meta-Analysis
por: Mallet, Jasmina, et al.
Publicado: (2020) -
Prevalence of Subthreshold Hypomania and Impact on Internal Validity of RCTs for Major Depressive Disorder: Results from a National Epidemiological Sample
por: Hoertel, Nicolas, et al.
Publicado: (2013) -
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review
por: Mallet, Jasmina, et al.
Publicado: (2021) -
Impact of DRD2/ANKK1 and COMT Polymorphisms on Attention and Cognitive Functions in Schizophrenia
por: Nkam, Irene, et al.
Publicado: (2017) -
Sustaining the unsustainable: Rapid implementation of a Support Intervention for Bereavement during the COVID-19 pandemic
por: Mallet, Jasmina, et al.
Publicado: (2021)